Interim data for ACT III: Phase II trial of PF-04948568 (CDX-110) in combination with temozolomide (TMZ) in patients (pts) with glioblastoma (GBM).
Published
Journal Article
Full Text
Duke Authors
Cited Authors
- Lai, R; Recht, LD; Reardon, DA; Paleologos, N; Groves, MD; Rosenfeld, MR; Meech, S; Davis, TA; Pavlov, D; Sampson, JH
Published Date
- May 20, 2010
Published In
Volume / Issue
- 28 / 15_suppl
Start / End Page
- 2014 - 2014
Published By
Electronic International Standard Serial Number (EISSN)
- 1527-7755
International Standard Serial Number (ISSN)
- 0732-183X
Digital Object Identifier (DOI)
- 10.1200/jco.2010.28.15_suppl.2014
Language
- en